Drug treatments and interactions, disease progression and quality of life in ALS patients.

Diamanti, Luca; Bianchi, Elisa; Mucaj, Klodjana; Cereda, Cristina; Garattini, Silvio; Beghi, Ettore; Pupillo, Elisabetta

Diamanti, Luca; Bianchi, Elisa; Mucaj, Klodjana; Cereda, Cristina; Garattini, Silvio; Beghi, Ettore; Pupillo, Elisabetta.

Afiliación

Diamanti L; IRCCS Mondino Foundation, Pavia, Italy.
Bianchi E; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy, and.
Mucaj K; University of Pavia, Pavia, Italy.
Cereda C; IRCCS Mondino Foundation, Pavia, Italy.
Garattini S; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy, and.
Beghi E; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy, and.
Pupillo E; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy, and.

Amyotroph Lateral Scler Frontotemporal Degener ; 23(5-6): 415-423, 2022 08.

Article en En | MEDLINE | ID: mdl-34964422

Asunto(s)

Esclerosis Amiotrófica Lateral; Enfermedades Neurodegenerativas; Esclerosis Amiotrófica Lateral/diagnóstico; Progresión de la Enfermedad; Humanos; Calidad de Vida; Encuestas y Cuestionarios

Palabras clave

Drug interactions; amyotrophic lateral sclerosis; quality of life; rare disease; treatments

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Neurodegenerativas / Esclerosis Amiotrófica Lateral Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Amyotroph Lateral Scler Frontotemporal Degener Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google